icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
 
 
 
Algorithms Using Noninvasive Tests Can Accurately Identify Patients
With Advanced Fibrosis Due to NASH: Data From the STELLAR Clinical Trials

 
 
  Reported by Jules Levin
AASLD 2018 Nov 9-13 SF

zobair

AASLD: Routinely Available Noninvasive Tests Discriminate Advanced Fibrosis Due to NASH in the Phase 3 STELLAR Trials of the ASK1 Inhibitor Selonsertib - (11/16/18)

1130181

1130182

1130183

1130184

1130185

1130186

1130187

1130188